More reads

• Drug hunters explore allostery’s advantages (Chemical & Engineering News)
• Roche fought through a bidding war to land its Spark buyout—and paid up big-time (Fierce Pharma)
• GE’s would-be HQ tower could be turned into labs (Boston Globe)